Argent Advisors, Inc.

SEC CIK: 0001426851
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Argent Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overview All 13F holders of CRVS Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2025

Holdings of CRVS by Argent Advisors, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−30,000−100.0%	Sold out	Holders
Q4 2025	30,000	$231.0K	0.1%	00.0%	Unchanged	Holders
Q3 2025	30,000	$221.1K	0.1%	00.0%	Unchanged	Holders
Q2 2025	30,000	$120.0K	<0.1%	+30,000	New	Holders